CMR strengthens radiation oncology through advanced molecular research that underpins high-quality radiotracer development. Their expertise supports the creation of compounds that improve tumour detection, delineation and biological characterisation—critical elements in planning precise radiotherapy.​ ​ Through our collaboration, Transmedic connects cancer centres across Southeast Asia with CMR’s science-driven solutions, elevating diagnostic accuracy and supporting more personalised treatment strategies.